OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-1361015
  • Global Cardiovascular Information System Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: April 2016 | Report Code: HHE-1361015

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

IT is emerging as a vital component among healthcare organizations, specifically in managing the rapidly growing healthcare data. Although there are several healthcare information systems (HIS) such as EMR, EHR, and PACS, the significant growth in cardiovascular diseases globally is driving the demand for cardiovascular information system (CVIS) among cardiologists... The increasing cases of heart diseases globally have escalated the demand for interventional cardiology surgeries. Cardiovascular operations face numerous problems such as outdated technology, multiple systems, and disparate silos of data and hence many clinics and healthcare providers are seeking to modernize their cardiovascular department with CVIS. 

Cardiovascular information system (CVIS) can be defined as the web based compilation of research material software architecture and clinical information that helps in facilitating information exchange, decision support and scientific advancement of the field. It is a data driven field that stores all the information related to patients suffering from cardiovascular disease. Along with the business operations such as business analytics and making bills, CVIS also provides dynamic reporting like informatics, measurements and images for reliable and effective reports of patients. Cardiovascular information system market is already at its highest point and has very good chances that the field will be witnessing further growth. The global cardiovascular information system market has the CAGR of 8.57% during the forecast period2016-2023.

Enterprise wide management and IT systems have become the key trends of healthcare organizations. Healthcare organizations are looking at opportunities with cloud computing by allowing quick access to computing and large storage facilities. 

The major drivers of cardiovascular information system include:

  • Increasing cases of CVDs
  • Increasing focus on operational excellence
  • Rising adoption of healthcare IT





Although creating an enterprise imaging system has now become an ultimate goal of many organizations, the cost of implementing an enterprise system is a major restraint. Also consolidation of hospitals is one of the major concerns before the customers with respect to data security and protection of patients’ personal data. Interoperability and integration issues are most common in such cases. For example, merging of various databases from different hospitals place major concern about the legacy systems from multiple vendors such that whether they need to be replaced or integrated.

CVIS has improved the way of treatment a lot by reducing door to treatment time, quick responses to physician requests, and so on. For example, the average door to ECG time has reduced to eight minutes as compared to 15-16 minutes before CVI analytics tools. Also, with the advent of new analytics software the report data can be used quickly analysed to provide immediate results.

Source: OBRC Analysis

The report is widely segmented on the basis of components, system type, mode of operation and application. Components is further segmented into:

  • Software Components
  • Hardware Components
  • Service Components





System is sub-segmented into:

  • CVIS
  • CPACS




The end-user segment is further sub-segmented into:

  • Hospitals
  • Diagnostic centers




Mode of Operation is sub-segmented into:

  • Web-Based CVIS
  • Onsite CVIS
  • Cloud-Based CVIS





 Application is sub-segmented into:

  • Catheterization Lab CVIS Solutions
  • Echocardiography Lab CVIS Solutions
  • Electrophysiology Lab CVIS Solutions
  • Nuclear Cardiology CVIS Solutions
  • Cardiothoracic Centre CVIS Solutions
  • Ecg/Holter Monitoring CVIS Solutions
  • Pacemaker/lCD Lab CVIS Solutions
  • Heart failure Centre CVIS Solutions
  • Outpatient clinic CVIS Solutions
  • Other Applications Solutions












 The revenue for the above application and end-user segments are specific to the global cardiovascular information system market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up component segment.

Geographically, the global CVIS market is segmented into:

  • North America (U.S. & Canada)
  • Asia-Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of the World






The report provides an extensive segmentation of the global cardiovascular information system market which includes segmentation by cardiology specialty applications, system type, component, mode of operations, and end user. The various Cardiology speciality applications include catheterization lab CVIS solution, echocardiography lab CVIS Solution, electrophysiology lab CVIS solution, nuclear cardiology CVIS solution, cardiothoracic center CVIS Solution, ECG studies/Holter monitoring CVIS solution, Pacemaker/ICD lab CVIS solution, heart failure centers CVIS solution, outpatient clinics CVIS solution, and other applications. 

On the basis of end user, the market is segmented into hospitals and diagnostic centres. v. The significant increase in investment in hospitals by both public and private sectors, the purchasing power of hospitals is higher than that of diagnostic centers. The segment is also expected to grow at highest CAGR during the forecast period. 

By system, the global cardiovascular information system market is segmented as CVIS and CPACS. Currently, the market is dominated by CVIS and the segment is expected to grow at the highest CAGR. CVIS has made immense contribution in improving the workflow and process. CVIS are comparatively more data driven than CPACS. Moreover, they have the ability to provide dynamic reporting (images, informatics, measurements, etc.) that are structured in a template-type format for efficiency and consistent delivery of patient reports. On the other hand, CPACS mainly focuses on storing and retrieving cardiology – centric images.

On the basis of component, the market is segmented into software, services, and hardware. Software segment contributes to highest share of the total market share. The growing adoption of cloud based services by the hospitals and development of government regulations for data protection and data security is expected to drive the growth of service segment during the forecasted period of 2016-2023. Also increasing focus of hospitals on the development of IT infrastructure is expected to give rise to the hardware segment. However, the report projects the service component to grow at the highest CAGR during 2016-2023

The global cardiovascular information systems market is dominated by North America with approx. 38% market share, followed by Europe. During the forecast period, Asia Pacific is expected to grow at the highest CAGR. China, India, Japan, and Australia are expected to lead the APAC market by 2023. However, North America will continue to lead the global CVIS market in the forecast period. 

The major market players of the global CVIS market are:

  • PHILIPS HEALTHCARE
  • MERGE HEALTHCARE
  • SIEMENS HEALTHCARE
  • FUJIFILM MEDICAL SYSTEMS
  • MCKESSON CORPORATION
  • CERNER CORPORATION








Major players in the cardiovascular information systems market include Philips Healthcare, McKesson Corporation, GE Healthcare, Siemens Healthcare, Merge Healthcare, Lumedx, Agfa Healthcare, Fujifilm Medical Systems, Digisonics, and Cerner Corporation. In the current market scenario, most of the CVIS vendors are focusing to build a single point of access with an integrated or single platform with multiple software modules. They are working towards consolidation of their cath lab reporting, electrocardiogram (ECG) management, hemodynamics, echo PACS (picture archiving and communication systems), nuclear medicine, advanced visualization imaging, and other specialty modalities into a single CVIS. The key players are focusing on new product developments, partnerships, expansions, collaborations and R & D investments.

For instance, Philips acquired Spectranetics Corporation, the leader in vascular intervention on 28th of June, 2017. By this acquisition Philips accelerated the expansion of image-guided therapy devices for the treatment of cardiac and other vascular disease. Also, Philips acquired Tom Tec imaging systems on 18thjuly 2017. Ton tec imaging system company is a provider of intelligent image analysis software for diagnosticultra sound.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as in Philips acquired Spectranetics Corporation on 28Th of June 2017.
  • Provide in detail the different segments such as application  and end-users which affect the global cardiovascular information system market.
  • Provide you the patent analysis of the global cardiovascular information system market.
  • Identify and understand the strengths, opportunities, challenges and threats of the global cardiovascular information system market.
  • Provide revenues of major players of the market such as Philips healthcare, Merge healthcare.
  • Provide you various regulatory policies which affect the global cardiovascular information system market.








How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global Cardiovascular information system Solutions market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global cardiovascular information system market such as growth and innovations in products & equipment’s and rising demand for technically progression & diagnosis of diseases and so on.  For each market segments covered in global cardiovascular information system report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the cardiovascular information system industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

 Key findings of global cardiovascular information system market are as follows:

  • North America generated the largest revenue share in 2016.
  • Merger & Acquisition is the key strategy adopted by the various market players of global cardiovascular information system market.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL CARDIOVASCULAR INFROMATION SYTEM MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        RISING INCIDENCE AND PREVALENCE OF CVDS

3.1.2.        INCREASING FOCUS ON OPERATIONAL EXCELLENCE

3.1.3.         RISING ADOPTION OF HEALTHCARE IT

3.2. MARKET RESTRAINTS

3.2.1.        HIGH COST OF INSTALLATION OF CVIS

3.2.2.        RELUCTANCE DUE TO SECURITY CONCERNS

3.3. MARKET OPPORTUNITIES

3.3.1.1.  CLOUD BASED HEALTHCARE SYSTEMS TO ACCELERATE MARKET GROWTH

3.3.1.2.  RISING MEDICAL TOURISM IN DEVELOPING REGIONS 

3.3.2.         MARKET CHALLENGES

3.3.2.1.  Integration & Interoperability of CVIS with existing system

4.      GLOBAL CARDIOVASCULAR MARKET BY COMPONENT

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL SOFTWARE COMPONENTS COMPONENT MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL HARDWARE COMPONENTS  COMPONENT MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.3.      GLOBAL SERVICE COMPONENTS COMPONENT MARKET

4.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.3.4.  KEY CONCLUSIONS

5.      GLOBAL CARDIOVASCULAR MARKET BY SYSTEM TYPE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL CVIS MARKET MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL CPACS MARKET MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

6.      GLOBAL CARDIOVASCULAR MARKET BY MODE OF OPERATION

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL WEB-BASED CVIS MODE OF OPERATION MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL ONSITE CVIS MODE OF OPERATION MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

6.5.3.      GLOBAL CLOUD-BASED CVIS MODE OF OPERATION MARKET

6.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.3.4.  KEY CONCLUSIONS

7.      CVIS MARKET BY END USER

7.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.1.1.3.  MARKET PARTICIPANTS AND PRODUCTS

7.1.1.4.  KEY CONCLUSIONS

7.1.2.      GLOBAL CVIS MARKET BY HOSPITALS

7.1.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.1.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.1.2.3.  MARKET PARTICIPANTS AND PRODUCTS

7.1.2.4.  KEY CONCLUSIONS

7.1.3.     

8.      GLOBAL CARDIOVASCULAR MARKET END USER

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.5.1.      GLOBAL CATHETERIZATION LAB CVIS SOLUTIONS MARKET

8.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.1.4.  KEY CONCLUSIONS

8.5.2.      GLOBAL ECHOCARDIOGRAPHY LAB CVIS SOLUTIONS MARKET

8.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.2.4.  KEY CONCLUSIONS

8.5.3.      GLOBAL ELECTROPHYSIOLOGY LAB CVIS SOLUTIONS MARKET

8.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.3.4.  KEY CONCLUSIONS

8.5.4.      GLOBAL NUCLEAR CARDIOLOGY CVIS SOLUTIONS END USER MARKET

8.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.4.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.4.4.  KEY CONCLUSIONS

8.5.5.      GLOBAL CARDIOTHORACIC CENTRE CVIS SOLUTIONS END USER  MARKET

8.5.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.5.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.5.4.  KEY CONCLUSIONS

8.5.6.      GLOBAL ECG/HOLTER MONITORING CVIS SOLUTIONS END USER MARKET

8.5.6.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.6.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.6.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.6.4.  KEY CONCLUSIONS

8.5.7.      GLOBAL PACEMAKER/ICD LAB CVIS SOLUTIONS END USER MARKET

8.5.7.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.7.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.7.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.7.4.  KEY CONCLUSIONS

8.5.8.      GLOBAL HEART FAILURE CENTRE CVIS SOLUTIONS END USER MARKET

8.5.8.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.8.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.8.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.8.4.  KEY CONCLUSIONS

8.5.9.      GLOBAL OUTPATIENT CLINIC CVIS SOLUTIONS END USER MARKET

8.5.9.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.9.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.9.3.  MARKET PARTICIPANTS AND PRODUCTS

8.5.9.4.  KEY CONCLUSIONS

8.5.10.  GLOBAL OTHER APPLICATIONS END USER MARKET

8.5.10.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.10.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.10.3.                      MARKET PARTICIPANTS AND PRODUCTS

8.5.10.4.                      KEY CONCLUSIONS

 

9.       COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIES

9.1.1.        LIST OF MERGERS AND ACQUISITION

9.1.2.        LIST OF JOINT VENTURES

9.1.3.        LIST OF PRODUCT LAUNCHES

9.1.4.        LIST OF PARTNERSHIPS

10.   GEOGRAPHIC ANALYSIS

10.1.                  DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

10.2.                  COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

10.3.                  OPPORTUNITY MATRIX

10.4.                  GLOBAL CARDIOVASCULAR MARKET BY REGION 2015-2024  

10.4.1.  NORTH AMERICA

10.4.1.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.1.2.                      TOP COUNTRY ANALYSIS

10.4.1.2.1.  U.S.

10.4.1.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.1.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.1.2.1.3.           KEY CONCLUSIONS

10.4.1.2.2.  CANADA

10.4.1.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.1.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.1.2.2.3.           KEY CONCLUSIONS

10.4.2.  EUROPE

10.4.2.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.2.2.                      TOP COUNTRY ANALYSIS

10.4.2.2.1.  UK

10.4.2.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.1.3.           KEY CONCLUSIONS

10.4.2.2.2.  FRANCE

10.4.2.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.2.3.           KEY CONCLUSIONS

10.4.2.2.3.  GERMANY

10.4.2.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.3.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.3.3.           KEY CONCLUSIONS

10.4.2.2.4.  SPAIN

10.4.2.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.4.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.4.3.           KEY CONCLUSIONS

10.4.2.2.5.  REST OF EUROPE

10.4.2.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.2.2.5.3.           KEY CONCLUSIONS

10.4.3.  ASIA PACIFIC

10.4.3.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.3.2.                      TOP COUNTRY ANALYSIS

10.4.3.2.1.  CHINA

10.4.3.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.1.3.           KEY CONCLUSIONS

10.4.3.2.2.  INDIA

10.4.3.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.2.3.           KEY CONCLUSIONS

10.4.3.2.3.  JAPAN

10.4.3.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.3.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.3.3.           KEY CONCLUSIONS

10.4.3.2.4.  AUSTRALIA

10.4.3.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.4.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.3.2.4.3.           KEY CONCLUSIONS

10.4.3.2.5.  REST OF ASIA PACIFIC

10.4.3.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.3.2.5.3.           KEY CONCLUSIONS

10.4.4.  ROW

10.4.4.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.4.2.                      TOP COUNTRY ANALYSIS

10.4.4.2.1.  LATIN AMERICA

10.4.4.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.4.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.4.2.1.3.           KEY CONCLUSIONS

10.4.4.2.2.  MIDDLE EAST & AFRICA

10.4.4.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.4.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.4.2.2.3.           KEY CONCLUSIONS

11.   COMPANY PROFILES

11.1.                  ALCATEL–LUCENT (FRANCE)

11.1.1.   OVERVIEW

11.1.2.   PRODUCT PORTFOLIO

11.1.3.   STRATEGIC INITIATIVES

11.1.4.   SCOT ANALYSIS

11.2.                  AVAYA (U.S)

11.2.1.   OVERVIEW

11.2.2.   PRODUCT PORTFOLIO

11.2.3.   STRATEGIC INITIATIVES

11.2.4.   SCOT ANALYSIS

11.2.5.   STRATEGIC ANALYSIS

11.3.                  CISCO (U.S)

11.3.1.   OVERVIEW

11.3.2.   PRODUCT PORTFOLIO

11.3.3.   STRATEGIC INITIATIVES

11.3.4.   SCOT ANALYSIS

11.3.5.   STRATEGIC ANALYSIS

11.4.                  COMPUTER SCIENCES CORPORATION (CSC) (US)

11.4.1.   OVERVIEW

11.4.2.   PRODUCT PORTFOLIO

11.4.3.   STRATEGIC INITIATIVES

11.4.4.   SCOT ANALYSIS

11.4.5.   STRATEGIC ANALYSIS

11.5.                  HEWLETT-PACKARD (U.S)

11.5.1.   OVERVIEW

11.5.2.   PRODUCT PORTFOLIO

11.5.3.   STRATEGIC INITIATIVES

11.5.4.   SCOT ANALYSIS

11.5.5.   STRATEGIC ANALYSIS

11.6.                  IBM (U.S)

11.6.1.   OVERVIEW

11.6.2.   PRODUCT PORTFOLIO

11.6.3.   STRATEGIC INITIATIVES

11.6.4.   SCOT ANALYSIS

11.6.5.   STRATEGIC ANALYSIS

11.7.                  MICROSOFT (US)

11.7.1.   OVERVIEW

11.7.2.   PRODUCT PORTFOLIO

11.7.3.   STRATEGIC INITIATIVES

11.7.4.   SCOT ANALYSIS

11.7.5.   STRATEGIC ANALYSIS

11.8.                  POLYCOM (US)

11.8.1.   OVERVIEW

11.8.2.   PRODUCT PORTFOLIO

11.8.3.   STRATEGIC INITIATIVES

11.8.4.   SCOT ANALYSIS

11.8.5.   STRATEGIC ANALYSIS

11.9.                  VERIZON COMMUNICATION

11.9.1.   OVERVIEW

11.9.2.   PRODUCT PORTFOLIO

11.9.3.   STRATEGIC INITIATIVES

11.9.4.   SCOT ANALYSIS

11.9.5.   STRATEGIC ANALYSIS

11.10.              VOSS (US)

11.10.1.                       OVERVIEW

11.10.2.                       PRODUCT PORTFOLIO

11.10.3.                       STRATEGIC INITIATIVES

11.10.4.                       SCOT ANALYSIS

11.10.5.                       STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL CARDIOVASCULAR MARKET BY COMPONENTS   2015-2024 ($ MILLION)

2.       GLOBAL SOFTWARE COMPONENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL HARDWARE COMPONENTS  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL SERVICE COMPONENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL CARDIOVASCULAR MARKET BY SYSTEM TYPE  2015-2024 ($ MILLION)

6.       GLOBAL CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

8.       GLOBAL WEB-BASED CVIS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL ONSITE CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL CLOUD-BASED CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL CVIS MARKET BY END USER  HOSPITALS MARKET BY VERTICAL 2015-2024 ($ MILLION)

12.   GLOBAL CATHETERIZATION LAB CVIS  BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL ECHOCARDIOGRAPHY LAB CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL INSURANCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL CARDIOVASCULAR MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL ELECTROPHYSIOLOGY LAB CVIS SOLUTIONS BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL NUCLEAR CARDIOLOGY CVIS SOLUTIONS BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL CARDIOTHORACIC CENTRE CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL ECG/HOLTER MONITORING CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL PACEMAKER/ICD LAB CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

21.   GLOBAL HEART FAILURE CENTRE CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL OUTPATIENT CLINIC CVIS SOLUTIONS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

23.   GLOBAL OTHER APPLICATIONS MARKET MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

24.   NORTH AMERICA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

25.   EUROPE CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

26.   ASIA PACIFIC CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

27.   REST OF THE WORLD CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

28.   NORTH AMERICA CARDIOVASCULAR MARKET BY COMPONENTS   2015-2024 ($ MILLION)

29.   EUROPE CARDIOVASCULAR MARKET BY COMPONENTS   2015-2024 ($ MILLION)

30.   ASIA PACIFIC CARDIOVASCULAR MARKET BY COMPONENTS   2015-2024 ($ MILLION)

31.   REST OF THE WORLD FINTECH BLOCKCHAINMARKET BY COMPONENTS   2015-2024 ($ MILLION)

32.   NORTH AMERICA CARDIOVASCULAR  MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

33.   EUROPE CARDIOVASCULAR MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

34.   ASIA PACIFIC CARDIOVASCULAR  MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

35.   REST OF THE WORLD CARDIOVASCULAR  MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

36.   NORTH AMERICA CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

37.   EUROPE CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

38.   ASIA PACIFIC CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

39.   REST OF THE WORLD CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

40.   NORTH AMERICA CARDIOVASCULAR MARKET BY END USER 2015-2024 ($ MILLION)

41.   EUROPE CARDIOVASCULAR MARKET BY END USER 2015-2024 ($ MILLION)

42.   ASIA PACIFIC CARDIOVASCULAR MARKET BY END USER 2015-2024 ($ MILLION)

43.   REST OF THE WORLD CARDIOVASCULAR MARKET BY VERTICAL 2015-2024 ($ MILLION)

44.   UNITED STATES CARDIOVASCULAR  MARKET BY COMPONENTS    2015-2024 ($ MILLION)

45.   UNITED STATES CARDIOVASCULAR  MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

46.   UNITED STATES CARDIOVASCULAR  MARKET BY END USER  2015-2024 ($ MILLION)

47.   CANADA STATES CARDIOVASCULAR  MARKET BY COMPONENTS    2015-2024 ($ MILLION)

48.   CANADA CARDIOVASCULAR  MARKET BY SYSTEM TYPE 2015-2024 ($ MILLION)

49.   CANADA CARDIOVASCULAR  MARKET BY END USER  2015-2024 ($ MILLION)

50.   UK STATES CARDIOVASCULAR  MARKET BY COMPONENTS    2015-2024 ($ MILLION)

LIST OF FIGURES

1.       GLOBAL CARDIOVASCULAR MARKET BY COMPONENTS   2015-2024 ($ MILLION)

2.       GLOBAL SOFTWARE COMPONENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL HARDWARE COMPONENTS  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL SERVICE COMPONENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL CARDIOVASCULAR MARKET BY SYSTEM TYPE  2015-2024 ($ MILLION)

6.       GLOBAL CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL CARDIOVASCULAR MARKET MODE OF OPERATION 2015-2024 ($ MILLION)

8.       GLOBAL WEB-BASED CVIS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL ONSITE CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL CLOUD-BASED CVIS MARKET MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL CVIS MARKET BY END USER  HOSPITALS MARKET BY VERTICAL 2015-2024 ($ MILLION)

12.   GLOBAL CATHETERIZATION LAB CVIS  BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL ECHOCARDIOGRAPHY LAB CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL INSURANCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL CARDIOVASCULAR MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL ELECTROPHYSIOLOGY LAB CVIS SOLUTIONS BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL NUCLEAR CARDIOLOGY CVIS SOLUTIONS BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL CARDIOTHORACIC CENTRE CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL ECG/HOLTER MONITORING CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL PACEMAKER/ICD LAB CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

21.   GLOBAL HEART FAILURE CENTRE CVIS SOLUTIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL OUTPATIENT CLINIC CVIS SOLUTIONS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

23.   GLOBAL OTHER APPLICATIONS MARKET MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

24.   UNITED STATES (U.S.) CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

25.   CANADA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

26.   UNITED KINGDOM (UK) CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

27.   FRANCE CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

28.   GERMANY CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

29.   SPAIN CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

30.   ROE CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

31.   CHINA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

32.   INDIA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

33.   JAPAN CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

34.   AUSTRALIA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

35.   ROAPAC CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

36.   LATIN AMERICA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION)

37.   MENA CARDIOVASCULAR MARKET 2015-2024 ($ MILLION) 

 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.